Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China · Delayed Price · Currency is CNY 7.53
+0.01 (0.13%)
Feb 4, 2026, 10:25 AM CST
SHE:002349 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 224.79 | 212.65 | 247.7 | 212.23 | 160.7 | 110.99 |
Depreciation & Amortization | 76.31 | 76.31 | 85.34 | 109.93 | 102.5 | 83.99 |
Other Amortization | 0.2 | 0.2 | - | 2.84 | 3.18 | 2.35 |
Loss (Gain) From Sale of Assets | 0.2 | 0.2 | 0.09 | 0.06 | 0.58 | -3.32 |
Asset Writedown & Restructuring Costs | 2.13 | 2.13 | 4.52 | 16.96 | 16.7 | 153.67 |
Loss (Gain) From Sale of Investments | -8.19 | -8.19 | -7.07 | -29.46 | -31.44 | -10.37 |
Provision & Write-off of Bad Debts | 3.37 | 3.37 | 2.72 | 4.26 | 14.59 | -1.57 |
Other Operating Activities | 72.11 | 42.54 | 36.19 | 16.98 | 3.98 | -29.33 |
Change in Accounts Receivable | -11.17 | -11.17 | -40.56 | 125.18 | 9.28 | 2.32 |
Change in Inventory | 6.43 | 6.43 | 11.18 | -27.82 | -31.09 | 46.32 |
Change in Accounts Payable | -17.32 | -17.32 | -46.61 | -103.34 | 56.47 | -31.78 |
Change in Other Net Operating Assets | 4.44 | 4.44 | -5.05 | 29.53 | -4.15 | 2.38 |
Operating Cash Flow | 352.73 | 311.02 | 291.31 | 358.39 | 305.57 | 328.22 |
Operating Cash Flow Growth | 26.78% | 6.77% | -18.72% | 17.29% | -6.90% | 15.01% |
Capital Expenditures | -17.9 | -30.92 | -28.38 | -61.59 | -80.55 | -118.46 |
Sale of Property, Plant & Equipment | 0.15 | 0.12 | 0.26 | 0.09 | 2.61 | 22.88 |
Cash Acquisitions | - | - | - | - | - | 0.72 |
Divestitures | - | - | - | 71.41 | 0.41 | 23.21 |
Investment in Securities | -762.53 | -130.69 | -191.24 | 91.1 | 4.32 | -80.42 |
Other Investing Activities | -149.1 | 11.69 | 6.99 | 7.58 | 4.23 | 28.66 |
Investing Cash Flow | -885.38 | -105.81 | -212.37 | 108.59 | -68.97 | -123.41 |
Short-Term Debt Issued | - | 10 | 20.9 | 85.52 | 70.07 | - |
Long-Term Debt Issued | - | - | - | 3.3 | - | 137.5 |
Total Debt Issued | 0.2 | 10 | 20.9 | 88.82 | 70.07 | 137.5 |
Short-Term Debt Repaid | - | -20.9 | -21 | -163.9 | -157.27 | - |
Long-Term Debt Repaid | - | -1.34 | -1.24 | -29.7 | -22.8 | -351.5 |
Total Debt Repaid | -16.24 | -22.24 | -22.24 | -193.6 | -180.07 | -351.5 |
Net Debt Issued (Repaid) | -16.04 | -12.24 | -1.34 | -104.77 | -110 | -214 |
Issuance of Common Stock | 56.71 | - | - | - | - | 302.52 |
Common Dividends Paid | -64.1 | -75.55 | -65.98 | -54 | -44.5 | -19.95 |
Other Financing Activities | -20.59 | -20.23 | -26.84 | -23.27 | -21.71 | 11.21 |
Financing Cash Flow | -44.03 | -108.02 | -94.16 | -182.05 | -176.21 | 79.77 |
Foreign Exchange Rate Adjustments | 1.24 | 2.13 | 2 | 4.1 | -1.12 | -5.6 |
Net Cash Flow | -575.44 | 99.32 | -13.22 | 289.03 | 59.27 | 278.99 |
Free Cash Flow | 334.83 | 280.1 | 262.93 | 296.8 | 225.02 | 209.75 |
Free Cash Flow Growth | 36.67% | 6.53% | -11.41% | 31.90% | 7.28% | 598.37% |
Free Cash Flow Margin | 23.11% | 19.98% | 17.39% | 18.87% | 16.57% | 16.37% |
Free Cash Flow Per Share | 0.41 | 0.34 | 0.32 | 0.36 | 0.28 | 0.26 |
Cash Income Tax Paid | 158.27 | 156.55 | 171.77 | 131.1 | 120.84 | 117.02 |
Levered Free Cash Flow | 271.18 | 186.18 | 132.98 | 198.73 | 69.94 | 319.1 |
Unlevered Free Cash Flow | 271.18 | 187.01 | 134.59 | 202.98 | 78.03 | 331.38 |
Change in Working Capital | -18.19 | -18.19 | -78.17 | 24.6 | 34.78 | 21.79 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.